Sonavex, Inc.

Sonavex develops automated 3D ultrasound solutions for dialysis access care, enabling quantification and visualization of critical clinical data. The company specializes in vascular assessment and cannulation guidance for arteriovenous fistula management. Primary product lines include EchoSure, which automatically measures volumetric flow rate, diameter, and depth of blood vessels; EchoMark, a patented ultrasound marker designed specifically for blood vessel visualization and tracking; and EchoMap, an intuitive vessel mapping system supporting cannulation procedures. These solutions are designed for point-of-care use across multiple clinical settings. The company is led by a multidisciplinary team including physicians, scientists, and technologists focused on delivering clinical and economic value to patients and health systems. Sonavex's technology addresses critical gaps in dialysis vascular access management, where accurate vessel assessment and maturation monitoring are essential for patient outcomes. The company has gained recognition in medical technology media and maintains a physician-supported, patient-oriented development approach.